Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

May 22, 2025 |  

- PMLiVE

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next generation of oncology professionals advancing clinical practice and improving patient outcomes 

Fellows Program Returns—Stronger Than Ever

The Medscape ASCO Fellows Program is back for its second year, offering hematology/oncology fellows a chance to:

  • Participate in exclusive focus groups with Medscape Oncology
  • Attend and network with expert faculty at our symposia
  • Share their ASCO experiences live from the Medscape Studio

“We’re thrilled to bring the Fellows Program back to ASCO. This initiative not only supports the next generation of oncologists but also helps them engage in meaningful learning and connect directly with leaders in the field,” said Jelena Spyropoulos 

If you’re passionate about advancing cancer care, Medscape Oncology at ASCO 2025 is the place to be. Join us as we deliver education that drives change—because informed clinicians mean better outcomes for patients.

7 Symposia! Where Science Meets Practice:

This year’s Medscape Oncology symposia go beyond the latest data—they’re designed to translate emerging science into actionable clinical strategies for real-world practice. Here’s a look at what’s in store:

  • Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer: Translating Science into Clinical Practice– Explore how tumor-agnostic therapies are reshaping precision oncology through earlier detection and personalized treatment.

 

  • Myelofibrosis: Clinical Updates and Best Practices for the Community Hematology/Oncology Clinic: Updates for the Community Hematology/Oncology Clinic- Stay ahead with the latest in therapies, risk tools, and symptom management tailored for community practice.

 

  • The Gynecologic Oncology Clinic: Real-time Case Review of Patients With Endometrial or Ovarian Cancer: Walk through real patient cases with expert faculty to enhance your approach to diagnosing and treating gynecologic cancers.


  • Clinical Integration of Therapeutic Innovations in Glioma: Pathways to Improved Patient Outcomes: Explore how cutting-edge treatments are transforming glioma care—and how to apply them in practice.


  • Bispecific Antibodies in R/R FL and R/R DLBCL: Aligning on Clinical Best Practices Learn to leverage bispecific antibodies in relapsed/refractory lymphomas with emerging best practices.


  • Changing Your Practice in Squamous Cell Carcinoma of the Anal Canal: Uncover how new therapies and biomarkers are redefining standards in this underserved cancer type.


  • A Day in the Community Oncology Clinic: Exploring Molecularly Altered NSCLC: Explore real-world cases that showcase the impact of biomarker-driven treatments in NSCLC.

Register for the symposia here

Each session is built for clinical relevance, interactivity, and practical insights, so learners leave with tools they can apply immediately. All symposia will also be available for CME/CE credit at Medscape.org.

Elevating Education with Data-Driven Outcomes

Medscape Oncology will also debut three new e-publications on the ASCO website, showcasing the measurable impact of our programs on findings from a comprehensive patient survey on nonmelanoma skin cancer and breast cancer education. These publications demonstrate how education can drive real-world improvements in care.

  1. Patient perspectives on nonmelanoma skin cancer care: insights into treatment, barriers, and healthcare gaps –https://meetings.asco.org/abstracts-presentations/248219
  2. Enhancing care of patients with HR+/HER2- early breast cancer at high risk of recurrence through an expansive curriculum: real-world outcomes (RWO) a 6-month analysis https://meetings.asco.org/abstracts-presentations/244642
  3. Is increase in CME consumption associated with practice change in the real world? An empirical study among oncologists treating breast cancer https://meetings.asco.org/abstracts-presentations/248318

Want to learn more?

Contact Jelena Spyropoulos (jspyropoulos@medsacpe.net) for details on Medscape Oncology and our full ASCO 2025 programming.

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

Part 1 of the Medscape video interview series

Ahead of  Europe’s largest hematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr Loretta Nastoupil on the most important abstracts to look out for at EHA in lymphoma...

Medscape: Connect to the conversation

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in...

A Medscape 4-part video interview series

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in...